从ACCORD研究中再认识2型糖尿病强化降糖治疗

Re-understanding of Intensive Blood-glucose Control Therapy in Type 2 Diabetes Mellitus from ACCORD Study

心血管并发症是2型糖尿病患者的主要死亡风险。减少2型糖尿病患者的心血管病死亡风险是2型糖尿病患者临床治疗的重要目的。强化降糖治疗能减少糖尿病患者心血管并发症及糖尿病相关死亡,但不同的个体应有不同的强化降糖措施和不同的标准。对于老年人、糖尿病病程长、心脑血管疾病高危人群需要在注重安全性的基础上进行个体化治疗。

Cardiovascular complications were main vital risks to patients with type 2 diabetes mellitus. So reducing cardio- vascular risks was one important objective of clinic therapy in type 2 diabetes mellitus. Generally, intensive blood--glucose control therapy could reduce cardiovascular complications and diabetes-- related death, through individualized control meas- ures and standards should apply to different patients. The eider patients with diabetes who had high cardiovascular and ce- rebrovascular disease risks should be treated with individualized therapy on safety basis for the reason of long course of disease.